Journal
INFLAMMATORY BOWEL DISEASES
Volume 15, Issue 4, Pages 616-629Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1002/ibd.20652
Keywords
inflammatory bowel disease (IBD); proteomics; ulcerative colitis; Crohn's disease; biomarkers
Categories
Funding
- NIDDK NIH HHS [R24 DK064388, R21 DK077064-02, KO1-DK62264, R24-DK64388, R21 DK077064, K01 DK062264] Funding Source: Medline
Ask authors/readers for more resources
Inflammatory bowel diseases (IBD) are chronic, heterogeneous and multifactorial intestinal inflammatory disorders. Major challenges in IBD research include identification of major pathogenic alterations of genes/proteins as well as effective biomarkers for early diagnosis, prop. and prediction of therapeutic response. Since proteins govern cellular structure and biological function, a wide selection of proteomic approaches enables effective characterization of IBD pathogenesis by investigation the dynamic nature of protein expression, cellular and subcellular distribution. posttranslational modifications. and interactions at both the cellular and subcellular levels. The aims of this review are to 1) highlight the Current status of proteomic Studies of IBD, and 2) introduce the available and emerging proteomic technologies that have potential applications, ill file study of IBD. These technologies include various mass spectrometry technologies. quantitative proteomics (2D-PAGE, ICAT, SILAC, iTRAQ). protein/antibody multi-epitope-ligand cartography. This review also presents information and methodologies. front sample selection and enrichment to protein identification, that are not only essential but also particularly relevant to IBD research. The potential future application of these technologies is expected to have a significant impact oil the discovery of novel biomarkers and key pathogenic factors for IBD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available